Drug Profile
Research programme: Chlamydophila pneumoniae vaccines - Argonex/Wyeth
Alternative Names: Chlamydia pneumoniae vaccines research programme - Argonex/Wyeth Vaccines; Chlamydophila pneumoniae vaccines research programme - Argonex/Wyeth VaccinesLatest Information Update: 17 Nov 2006
Price :
$50
*
At a glance
- Originator Argonex; Wyeth
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chlamydial infections
Most Recent Events
- 17 Nov 2006 Discontinued - Preclinical for Chlamydial infections in USA (unspecified route)
- 26 Mar 2002 American Home Products has changed its name and the names of its subsidiaries Wyeth-Ayerst and Wyeth-Lederle to Wyeth
- 14 Feb 2000 New profile